THE ROLE OF CA-125 IN THE EARLY DIAGNOSIS OF PROGRESSIVE DISEASE IN OVARIAN-CANCER

被引：78

作者：

VANDERBURG, MEL ^{[1
]}

LAMMES, FB ^{[1
]}

VERWEIJ, J ^{[1
]}

机构：

[1] UNIV AMSTERDAM,ACAD MED CTR,DEPT GYNECOL,1105 AZ AMSTERDAM,NETHERLANDS

来源：

ANNALS OF ONCOLOGY | 1990年 / 1卷 / 04期

关键词：

CA; 125; Ovarian cancer; Serum marker;

D O I：

10.1093/oxfordjournals.annonc.a057754

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The role of CA 125 determination in diagnosing progression of ovarian cancer was evluated in 98 patients of whom forty-nine had progressive disease. An elevated CA 125 level at the time of progression was found in 36 (73%) patients. In 31(63%) patients CA 125 increase preceded clinical progression for a median time lag of 4.5 months (range 0.5-29.5 months). The combination of seram CA 125, gynecological and general physical examination detected progression in 45 (92%) patients. The additional contribution of second-look surgely, CTscan, chest X-ray and routine laboratory tests was minimal. © 1990 Kluwer Academic Publishers.

引用

页码：301 / 302

页数：2

共 11 条

[1] A RADIOIMMUNOASSAY USING A MONOCLONAL-ANTIBODY TO MONITOR THE COURSE OF EPITHELIAL OVARIAN-CANCER
BAST, RC
KLUG, TL
STJOHN, E
JENISON, E
NILOFF, JM
LAZARUS, H
BERKOWITZ, RS
LEAVITT, T
GRIFFITHS, CT
PARKER, L
ZURAWSKI, VR
KNAPP, RC
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (15) : 883 - 887
[2] BERGMANN JF, 1987, CANCER-AM CANCER SOC, V59, P213, DOI 10.1002/1097-0142(19870115)59:2<213::AID-CNCR2820590206>3.0.CO
[3] 2-I
[4] EXPERIENCES WITH CA-125, A TUMOR-MARKER FOR MALIGNANT EPITHELIAL OVARIAN-TUMORS
CROMBACH, G
ZIPPEL, HH
WURZ, H
[J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 1985, 45 (04) : 205 - 212
[5] HUININK WWT, 1987, CANCER TREAT REV, V5, P77
[6] KREBS HB, 1986, OBSTET GYNECOL, V67, P473
[7] THE OVARIAN-CANCER ASSOCIATED ANTIGEN CA-125 IN PATIENTS WITH PLEURAL EFFUSIONS
LINDGREN, J
KUUSELA, P
HELLSTROM, PE
PETTERSSON, T
KLOCKARS, M
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (04): : 737 - 739
[8] RANDOMIZED TRIAL COMPARING 2 COMBINATION CHEMOTHERAPY REGIMENS (CHAP-5 V CP) IN ADVANCED OVARIAN-CARCINOMA
NEIJT, JP
TENBOKKELHUININK, WW
VANDERBURG, MEL
VANOOSTEROM, AT
WILLEMSE, PHB
HEINTZ, APM
VANLENT, M
TRIMBOS, JB
BOUMA, J
VERMORKEN, JB
VANHOUWELINGEN, JC
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (08) : 1157 - 1168
[9] NEIJT JP, 1984, LANCET, V2, P594
[10] VANDERBURG MEL, 1986, P AM SOC CLIN ONCOL, V123, pC480

← 1 2 →